I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy von Barker, AD, Sigman, CC, Kelloff, GJ, Hylton, NM, Berry, DA, Esserman, LJ

Volltext

Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival von Magbanua, M.J.M., Swigart, L.B., Wu, H.-T., Hirst, G.L., Yau, C., Wolf, D.M., Tin, A., Salari, R., Shchegrova, S., Pawar, H., Delson, A.L., DeMichele, A., Liu, M.C., Chien, A.J., Tripathy, D., Asare, S., Lin, C.-H.J., Billings, P., Aleshin, A., Sethi, H., Louie, M., Zimmermann, B., Esserman, L.J., van ‘t Veer, L.J.

Volltext

PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms von Trusheim, MR, Shrier, AA, Antonijevic, Z, Beckman, RA, Campbell, RK, Chen, C, Flaherty, KT, Loewy, J, Lacombe, D, Madhavan, S, Selker, HP, Esserman, LJ

Volltext

Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy von Du, L., Yau, C., Brown-Swigart, L., Gould, R., Krings, G., Hirst, G.L., Bedrosian, I., Layman, R.M., Carter, J.M., Klein, M., Venters, S., Shad, S., van der Noordaa, M., Chien, A.J., Haddad, T., Isaacs, C., Pusztai, L., Albain, K., Nanda, R., Tripathy, D., Liu, M.C., Boughey, J., Schwab, R., Hylton, N., DeMichele, A., Perlmutter, J., Yee, D., Berry, D., van't Veer, L., Valero, V., Esserman, L.J., Symmans, W.F.

Volltext

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial von Johansson, Annelie, Dar, Huma, van 't Veer, Laura J, Tobin, Nicholas P, Perez-Tenorio, Gizeh, Nordenskjöld, Anna, Johansson, Ulla, Hartman, Johan, Skoog, Lambert, Yau, Christina, Benz, Christopher C, Esserman, Laura J, Stål, Olle, Nordenskjöld, Bo, Fornander, Tommy, Lindström, Linda S

Volltext

Precision surgery and avoiding over-treatment von Hosseini, A, Khoury, A.L, Esserman, L.J

Volltext

The value of embedding: integrated palliative care for patients with metastatic breast cancer von Rabow, M., Small, R., Jow, A., Majure, M., Chien, A., Melisko, M., Belkora, J., Esserman, L. J., Rugo, H.

Volltext

Dynamic High-Spatial-Resolution MR Imaging of Suspicious Breast Lesions: Diagnostic Criteria and Interobserver Variability von Kinkel, Karen, Helbich, Thomas H, Esserman, Laura J, Barclay, John, Schwerin, Ellen H, Sickles, Edward A, Hylton, Nola M

Volltext

Mammographic screening detects low-risk tumor biology breast cancers von Drukker, C. A., Schmidt, M. K., Rutgers, E. J. T., Cardoso, F., Kerlikowske, K., Esserman, L. J., van Leeuwen, F. E., Pijnappel, R. M., Slaets, L., Bogaerts, J., van’t Veer, L. J.

Volltext

The Novel Application of Genomic Profiling Assays to Shorten Inactive Status for Potential Kidney Transplant Recipients With Breast Cancer von Mukhtar, R. A., Piper, M. L., Freise, C., Van't Veer, L. J., Baehner, F. L., Esserman, L. J.

Volltext

Biology of breast cancer in Nigerian women: a pilot study von Adisa, C A, Eleweke, N, Alfred, Au A, Campbell, M J, Sharma, R, Nseyo, O, Tandon, V, Mukhtar, R, Greninger, A, Risi, J Di, Esserman, L J

Volltext

MR Imaging of the Breast in Patients with Positive Margins After Lumpectomy: Influence of the Time Interval Between Lumpectomy and MR Imaging von Frei, Kathrin A, Kinkel, Karen, Bonel, Harald M, Lu, Ying, Esserman, Laura J, Hylton, Nola M

Volltext

Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time? von Esserman, L. J., Alvarado, M. D., Howe, R. J., Mohan, A. J., Harrison, B., Park, C., O’Donoghue, C., Ozanne, E. M.

Volltext

Building Bridges Between Physicians and Patients: Results of a Pilot Study Examining New Tools for Collaborative Decision Making in Breast Cancer von SEPUCHA, K. R, BELKORA, J. K, TRIPATHY, D, ESSERMAN, L. J

Volltext

The quality of life index: a pilot study integrating treatment efficacy and quality of life in oncology von Basu, A., Philip, E. J., Dewitt, B., Hanmer, J., Chattopadhyay, A., Yau, C., Melisko, M. E., Esserman, L. J.

Volltext

Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice von Jabrane-Ferrat, N, Campbell, M J, Esserman, L J, Peterlin, B M

Volltext

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial von Shieh, Yiwey, Eklund, Martin, Madlensky, Lisa, Sawyer, Sarah D, Thompson, Carlie K, Stover Fiscalini, Allison, Ziv, Elad, Van't Veer, Laura J, Esserman, Laura J, Tice, Jeffrey A

Volltext

Personalized early detection and prevention of breast cancer: ENVISION consensus statement von Pashayan, Nora, Antoniou, Antonis C., Ivanus, Urska, Esserman, Laura J., Easton, Douglas F., French, David, Sroczynski, Gaby, Hall, Per, Cuzick, Jack, Evans, D. Gareth, Simard, Jacques, Garcia-Closas, Montserrat, Schmutzler, Rita, Wegwarth, Odette, Pharoah, Paul, Moorthie, Sowmiya, De Montgolfier, Sandrine, Baron, Camille, Herceg, Zdenko, Turnbull, Clare, Balleyguier, Corinne, Rossi, Paolo Giorgi, Wesseling, Jelle, Ritchie, David, Tischkowitz, Marc, Broeders, Mireille, Reisel, Dan, Metspalu, Andres, Callender, Thomas, de Koning, Harry, Devilee, Peter, Delaloge, Suzette, Schmidt, Marjanka K., Widschwendter, Martin

Volltext

Population-based screening for cancer: hope and hype von Shieh, Y, Eklund, M, Sawaya, GF, Black, WC, Kramer, BS, Esserman, LJ

Volltext

Major Histocompatibility Complex Class II Transcriptional Platform: Assembly of Nuclear Factor Y and Regulatory Factor X (RFX) on DNA Requires RFX5 Dimers von Jabrane-Ferrat, Nabila, Nekrep, Nada, Tosi, Giovanna, Esserman, Laura J, Peterlin, B Matija

Volltext